A limited sampling strategy for estimation of the cladribine plasma area under the concentration versus time curve after intermittent i.v. infusion, s.c. injection, and oral administration

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 6, 1996, Pages 536-540

  Liliemark, Jan ^a   Albertioni, Freidoun ^a   Juliusson, Gunnar ^b   Eksborg, Staffan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cladribine; Pharmacokinetics; Stepwise linear regression; Therapeutic drug monitoring

Indexed keywords

CLADRIBINE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HAIRY CELL LEUKEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MATHEMATICAL MODEL; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; SUBCUTANEOUS DRUG ADMINISTRATION; THYMOMA;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; CLADRIBINE; DRUG MONITORING; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LINEAR MODELS; MALE; MIDDLE AGED;

EID: 0029826127     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050523     Document Type: Article

References (16)

1. Albertioni F, Juliusson G, Liliemark J (1993) On the bioavailability of 2-chloro-2′-deoxyadenosine (CdA): the influence of food and omeprazole. Eur J Clin Pharmacol 44:579-582
2. Albertioni F, Pettersson B, Reichelovà V, Juliusson G, Liliemark J (1994) Analysis of 2-chloro-2′-deoxyadenosine in human blood samples and urine by high-performance liquid chromatography using solid-phase extraction. Ther Drug Monit 16:413
3. Bryson H, Sorkin E (1993) Cladribine. A review of its pharmacodynamics, pharmacokinetics and therapeutic potential in the treatment of haematological malignancies. Drugs 46:872
4. Chabot GG (1995) Limited sampling models for simultaneous estimation of the pharmacokinetics of irinotecan and its active metabolite SN-38. Cancer Chemother Pharmacol 36:463
5. Eksborg S, Albertioni F, Beck O, Peterson C, Seideman P (1994) Methotrexate in rheumatoid arthritis - a limited sampling strategy for estimation of the area under the plasma concentration versus time curve. Ther Drug Monit 16:560
6. Juliusson G, Liliemark J (1992) High complete remission rate from 2-chloro-2′-deoxyadenosine (CdA) in previously treated patients with B-cell chronic lymphocytic leukemia; response predicted by rapid decrease of blood lymphocyte count. J Clin Oncol 11:679
7. Juliusson G, Johnson S, Christiansen J, Kimby E, Björkholm M, Lärfars G, Liliemark J (1993) Oral 2-chlorodeoxyadenosine (CdA) as primary treatment for symptomatic chronic lymphocytic leukemia (CLL). Bloood 10 [Suppl 1] : 141
8. Juliusson G, Heldal D, Hippe E, Hedenus M, Wallman K, Malm C, Stolt C, Evensen S, Albertioni F, Tjønnfjord G, Lenkei R, Liliemark J (1995) Subcutaneous injection of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. J Clin Oncol 13:989
9. Liliemark J, Juliusson G (1991) On the pharmacokinetics of 2-chloro-2′-deoxyadenosine in humans. Cancer Res 51:5570
10. Liliemark J, Pettersson B, Juliusson G (1991) Determination of 2-chloro-2′-deoxyadenosine in human plasma. Biomed Chromatogr 5:262
11. Liliemark J, Albertioni F, Hassan M, Juliusson G (1992) On the bioavailability of oral and subcutaneous 2-chloro-2′-deoxyadenosine in humans; alternative routes of administration. J Clin Oncol 10:1514
12. Oberhuber G, Schmid T, Thaler W, Kaltenbacher A, Schirmer M, Liliemark J, Herbst P, Geisen F, Margreiter R, Konwalinka G (1994) 2-Chlorodeoxyadenosine in combination with cycloporine prevents rejection after allogeneic small bowel transplantation. Transplantation 58:743
13. Reid J, Bagniewski P, Richardson R, Marks R, Letendre L, Tefferi A, Ames M (1994) Clinical pharmacology of 2-chlorodeoxyadenosine in patients with solid tumors, chronic leukemia or lymphoma. Proceedings 8th NCI-EORTC symposium on new drugs in cancer therapy, Amsterdam, 15 18 March, p 174
14. Sipe J, Romine J, Koziol J, McMillan R, Zyroff J, Beutler E (1994) Cladribine in treatment of chronic progressive multiple sclerosis. Lancet 334:9
15. Sørensen BT, Strømgren A, Jakobsen P, Jakobsen A (1993) A limited sampling method for estimation of the carboplatin area under the curve. Cancer Chemother Pharmacol 31:324
16. Stromgren AS, Sørensen BT, Jakobsen P, Jakobsen A (1993) A limited sampling method for estimation of the etoposide area under the curve. Cancer Chemother Pharmacol 31:226